Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -87.80M
March 31, 2026 -14.21M
December 31, 2025 -12.78M
September 30, 2025 1.978M
June 30, 2025 -15.58M
March 31, 2025 -7.323M
December 31, 2024 -1.614B
September 30, 2024 1.379B
June 30, 2024 1.425M
March 31, 2024 -2.415M
December 31, 2023 -10.19M
September 30, 2023 -5.135M
June 30, 2023 -0.82M
March 31, 2023 -1.427M
December 31, 2022 2.832M
September 30, 2022 -0.647M
June 30, 2022 -2.243M
March 31, 2022 -5.67M
December 31, 2021 -13.05M
September 30, 2021 -20.84M
June 30, 2021 -26.14M
March 31, 2021 -5.852M
December 31, 2020 -48.60M
September 30, 2020 5.257M
June 30, 2020 -2.098M
Date Value
March 31, 2020 -15.94M
December 31, 2019 -4.442M
September 30, 2019 1.547M
June 30, 2019 -8.423M
March 31, 2019 -2.947M
December 31, 2018 -6.572M
September 30, 2018 -10.29M
June 30, 2018 -10.97M
March 31, 2018 -5.828M
December 31, 2017 -10.75M
September 30, 2017 -7.585M
June 30, 2017 -18.47M
March 31, 2017 27.24M
December 31, 2016 -33.82M
September 30, 2016 -15.50M
June 30, 2016 -23.72M
March 31, 2016 -8.439M
December 31, 2015 -16.41M
September 30, 2015 -18.14M
June 30, 2015 -15.44M
March 31, 2015 -13.86M
December 31, 2014 -17.57M
September 30, 2014 -14.90M
June 30, 2014 -12.88M
March 31, 2014 -12.16M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
The Ensign Group, Inc. -407.71M
Regional Health Properties, Inc. -0.498M
Chemed Corp. -28.24M
Oncologix Tech, Inc. --
InnovAge Holding Corp. -4.902M